leadf
logo-loader
TSX:WLLW OTCQB:CANSF

Willow Biosciences Inc.

Receive alerts
Market:
TSX
Market Cap:
$43.39 m
Price
0.55 CAD
Change
-8.33%
52 weeks high
1.00
52 weeks low
0.30

In brief

Willow is a Canadian biotechnology company based in Vancouver, Canada, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow's current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow's science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow's manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs.

Snapshot

The Canadian company has developed a proprietary biosynthetic process to manufacture the cannabis compound in commercial quantities